New test helps drug discoverers identify future cancer treatments

byInstitute of Cancer ResearchAn illustration of how the R2KD tool works Credit: Dr Maggie Liu, first authorResearchers have developed an investigative procedure that makes the early stages of d

Updated on: January 11,2024

New test helps drug discoverers identify future cancer treatments

byInstitute of Cancer ResearchAn illustration of how the R2KD tool works Credit: Dr Maggie Liu, first authorResearchers have developed an investigative procedure that makes the early stages of d

Updated on:January 11,2024

Study: Innovative pancreatic cancer treatment may rev up immune system

by University of Rochester Medical CenterImmune cells (orange) and blood vessels (green) inside a tumor. Credit: University of Rochester Medical CenterA University of Rochester Wilmot Cancer Inst

Updated on: March 01,2024

Study: Innovative pancreatic cancer treatment may rev up immune system

by University of Rochester Medical CenterImmune cells (orange) and blood vessels (green) inside a tumor. Credit: University of Rochester Medical CenterA University of Rochester Wilmot Cancer Inst

Updated on:March 01,2024

New hormonal agent may slow progression of early-stage prostate cancer during active surveillance

byWolters Kluwer HealthPositive biopsy-free survival with 95% confidence limits (shaded gray areas). Credit:Journal of Urology(2023). DOI: 10.1097/JU.0000000000003038For men with ear

Updated on: January 12,2024

New hormonal agent may slow progression of early-stage prostate cancer during active surveillance

byWolters Kluwer HealthPositive biopsy-free survival with 95% confidence limits (shaded gray areas). Credit:Journal of Urology(2023). DOI: 10.1097/JU.0000000000003038For men with ear

Updated on:January 12,2024

A new therapeutic strategy to improve treatment of aggressive endometrial cancer

by Autonomous University of BarcelonaERK5 inhibition impairs EC cell proliferation.AGenomic profiles of components of the MEK5-ERK5 pathway in EC patients obtained from Uterine Corpus

Updated on: February 23,2024

A new therapeutic strategy to improve treatment of aggressive endometrial cancer

by Autonomous University of BarcelonaERK5 inhibition impairs EC cell proliferation.AGenomic profiles of components of the MEK5-ERK5 pathway in EC patients obtained from Uterine Corpus

Updated on:February 23,2024

Gray hair and wrinkles at an early age lead researchers to potential new treatment for rare cancer

by University of CopenhagenSchematic representation of the PandaOmics application for a rapid biomarker discovery and target characterization in cancer. Gene expression signatures have been exami

Updated on: February 18,2024

Gray hair and wrinkles at an early age lead researchers to potential new treatment for rare cancer

by University of CopenhagenSchematic representation of the PandaOmics application for a rapid biomarker discovery and target characterization in cancer. Gene expression signatures have been exami

Updated on:February 18,2024

Scientists discover sweet spot of activity in immune system key to fighting cancer

by University of SouthamptonConcentrated CD40 receptions (grey wavy lines) on the immune cell surface. Credit: University of SouthamptonScientists at the University of Southampton have shown how

Updated on: March 12,2024

Scientists discover sweet spot of activity in immune system key to fighting cancer

by University of SouthamptonConcentrated CD40 receptions (grey wavy lines) on the immune cell surface. Credit: University of SouthamptonScientists at the University of Southampton have shown how

Updated on:March 12,2024

Metachronous pathology assessed in young-onset colorectal cancer survivors

The incidence rate of clinically significant metachronous colorectal pathology is 32 per 1,000 person-years after index young-onset colorectal cancer (YOCRC), according to a research letter published

Updated on: January 02,2024

Metachronous pathology assessed in young-onset colorectal cancer survivors

The incidence rate of clinically significant metachronous colorectal pathology is 32 per 1,000 person-years after index young-onset colorectal cancer (YOCRC), according to a research letter published

Updated on:January 02,2024

Novel bioassay predicts cancer patients' response to immunotherapy

byBen-Gurion University of the NegevIcAR response to fresh and fixed PDXs and generation of an IcAR score.(A) Schematic representation of the IcAR assay protocol. Following flow cytometry determ

Updated on: January 12,2024

Novel bioassay predicts cancer patients' response to immunotherapy

byBen-Gurion University of the NegevIcAR response to fresh and fixed PDXs and generation of an IcAR score.(A) Schematic representation of the IcAR assay protocol. Following flow cytometry determ

Updated on:January 12,2024

Researchers develop new marker for cancer cell motility

by Leipzig UniversityTwo aggregate states of cancer cell clusters. In blue: densely packed, more rounded cancer cells jam together and cannot move, reducing the risk of metastasis. In green: more

Updated on: February 18,2024

Researchers develop new marker for cancer cell motility

by Leipzig UniversityTwo aggregate states of cancer cell clusters. In blue: densely packed, more rounded cancer cells jam together and cannot move, reducing the risk of metastasis. In green: more

Updated on:February 18,2024

Certain cancers will likely rise exponentially due to COVID-19 screening delays

byAmerican College of SurgeonsCredit: Unsplash/CC0 Public DomainDelays in cancer screening during the COVID-19 pandemic will likely cause a significant increase in cancer cases that could have b

Updated on: February 18,2024

Certain cancers will likely rise exponentially due to COVID-19 screening delays

byAmerican College of SurgeonsCredit: Unsplash/CC0 Public DomainDelays in cancer screening during the COVID-19 pandemic will likely cause a significant increase in cancer cases that could have b

Updated on:February 18,2024

Study: GPs managing more skin cancer cases as cost of treatment climbs in Australia

by University of Sydney(A) Proportion of different skin cancer-related conditions managed in general practice, 2000–2016. (B) Management rate per 1,000 encounters of all skin cancer-related condi

Updated on: February 01,2024

Study: GPs managing more skin cancer cases as cost of treatment climbs in Australia

by University of Sydney(A) Proportion of different skin cancer-related conditions managed in general practice, 2000–2016. (B) Management rate per 1,000 encounters of all skin cancer-related condi

Updated on:February 01,2024

Early palliative care offers no extra benefit for mesothelioma patients

by Curtin UniversityCredit: CC0 Public DomainEarly specialist palliative care treatment does not improve the quality of life for patients diagnosed with the rare cancer mesothelioma when compared

Updated on: April 20,2024

Early palliative care offers no extra benefit for mesothelioma patients

by Curtin UniversityCredit: CC0 Public DomainEarly specialist palliative care treatment does not improve the quality of life for patients diagnosed with the rare cancer mesothelioma when compared

Updated on:April 20,2024